We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
- TG: TG? (2)
- MD: For Humans? (2)
- Accept - Yes
- LM: Sponsor? (2)
- Scheduling delegate's interim decisions and invitation for further comment: ACCS/ACMS, March 2017
- Scheduling delegate's interim decisions and invitation for further comment: ACCS/ACMS, March and July 2017
- Scheduling delegates' interim decisions and invitation for further comment: ACCS/ACMS, November 2017
- Publication of interim decisions amending, or not amending, the current Poisons Standard, June 2018
- Publication of interim decisions proposing to amend, or not amend, the current Poisons Standard, September 2018
- Publication of interim decisions amending, or not amending, the current Poisons Standard, February 2019
- Interim decisions and invitation for further comment on substances referred to the March 2019 ACMS/ACCS meetings
- Interim decisions and invitation for further comment on substances referred to the June 2019 ACMS/ACCS meetings
- Interim decisions and invitation for further comment on substances referred to the November 2019 ACMS/ACCS meetings
- Notice of interim decisions on proposed amendments to the Poisons Standard - ACMS/ACCS/Joint ACMS-ACCS meetings, March 2020
- Notice of interim decisions on proposed amendments to the Poisons Standard - ACMS and Joint ACMS-ACCS meetings, June 2020
- Notice of interim decisions on proposed amendments to the Poisons Standard - ACMS, ACCS and Joint ACMS-ACCS meetings, November 2020
- Scheduling delegate's final decisions, January 2017
- Scheduling delegate's final decisions, June 2017
- Scheduling delegate's final decisions, October 2017
- Scheduling delegate's final decisions, January 2018
- Final decisions amending, or not amending, the current Poisons Standard, April 2018
- Scheduling delegates' final decisions: NCEs, May 2018
- Revised final decisions amending, or not amending, the current Poisons Standard to correct for minor administrative errors, September 2018
- Final decisions amending, or not amending, the current Poisons Standard, November 2018
- Final scheduling decisions and reasons: NCEs and Appendix H
- Final decisions and reasons for NCEs, medicines and chemicals, November 2018
- Notice of a final decision to amend (or not amend) the current Poisons Standard, August 2019
- Delegate-only final decisions and reasons: NCEs, September 2019
- Notice of final decisions to amend (or not amend) the current Poisons Standard, November 2019
- Notice of final decisions to amend (or not amend) the current Poisons Standard, May 2020
- Public notice of final decisions - ACMS#29, ACCS#27, Joint ACMS-ACCS#24, March 2020
- Notice of final decisions to amend (or not amend) the current Poisons Standard, November 2020
- TGA approach to disclosure of commercially confidential information (CCI)
- Reduction of assessment fees for medical devices
- Guidelines for sterility testing of therapeutic goods
- AHMAC - Scheduling policy framework for medicines and chemicals, 2015
- Economic modelling and financial quantification of the regulatory impact of proposed changes to codeine scheduling
- Regulation impact statement: Codeine re-scheduling
- Therapeutic goods advertising compliance, 2018-19 annual report
- Regulation impact statement for reclassification of hip, knee and shoulder joint implants
- Regulation impact statement: General requirements for labels for medicines
- Regulator Performance Framework: Self-assessment Report, July 2016 to June 2017
- TGA stakeholder survey 2017
- Annual performance statistics report: July 2017 to June 2018
- TGA stakeholder survey 2018
- TGA consumer survey 2018
- Regulator Performance Framework: Self-assessment Report, July 2017 to June 2018
- Annual performance statistics report: July 2018 to June 2019
- Regulator Performance Framework: Self-assessment Report, July 2018 to June 2019
- Regulation essentials
- Guidance materials for permitted indications for listed medicines
- eCTD AU module 1 and regional information v3.1
- Electronic submission of individual case safety reports
- Medicine shortages/discontinuations: electronic notification form
- Listed and assessed listed medicines: application and submission user guide
- Australian manufacturing licences and overseas GMP certification
- Process to change a registered over-the-counter (OTC) medicine
- Biologicals application form - a step-by-step guide
- Completing the application form for an assessed listed medicine
- Information for applicants completing a pre-submission planning form